WHO Prequalified Vaccines

 

Last updated:  15/02/2019
233 presentation(s) for 146 vaccine(s)
PrequalifiedTypeCommercial NamePharmaceutical FormPresentationNo. of DosesManufacturerResponsible NRA
26/09/2006Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type bQuinvaxemLiquid: ready to useVial1Janssen Vaccines Corp.Ministry of Food and Drug Safety
11/03/1999Diphtheria-Tetanus Adsorbed DT VaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
06/04/2001Diphtheria-Tetanus-Pertussis (whole cell)DTP VaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
13/05/2004Hepatitis BHepatitis B Vaccine Recombinant Liquid: ready to useUniject1PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997Polio Vaccine - Oral (OPV) TrivalentOral polioLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997Polio Vaccine - Oral (OPV) TrivalentOral polioLiquid: ready to useVial20PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
11/03/1999Tetanus ToxoidTT vaccineLiquid: ready to useVial10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
11/03/1999Tetanus ToxoidTT vaccineLiquid: ready to useVial20PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
29/10/2003Tetanus ToxoidTT vaccineLiquid: ready to useUniject1PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
09/04/1997MeaslesMeasles vaccine Lyophilised active component to be reconstituted with excipient diluent before useVial + Ampoule10PT Bio Farma (Persero)National Agency of Drug and Food Control Indonesia
17/10/2001Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)5Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
10/12/2007Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)10Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
17/10/2001Yellow FeverYellow FeverLyophilised active component to be reconstituted with excipient diluent before useTwo vial set (active + excipient)50Bio-Manguinhos/FiocruzAgencia Nacional da Vigilancia Sanitaria
11/12/2001Hepatitis BHeberbiovac HBLiquid: ready to useVial1Centro de Ingenieria Genetica y BiotecnologiaCentro para el Control Estatal de la Calidad de los Medicamentos
11/12/2001Hepatitis BHeberbiovac HBLiquid: ready to useVial10Centro de Ingenieria Genetica y BiotecnologiaCentro para el Control Estatal de la Calidad de los Medicamentos
10/04/2018RabiesRabipurLyophilised active component to be reconstituted with excipient diluent before useVial1Chiron Behring Vaccines Private Ltd.Central Drugs Standard Control Organization
18/08/1997Haemophilus influenzae type bVaxem HIBLiquid: ready to useVial1Novartis Vaccines and Diagnostics S.r.lAgenzia Italiana del Farmaco
01/01/1987Hepatitis BEngerixLiquid: ready to useVial1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
01/01/1987Hepatitis BEngerixLiquid: ready to useVial10GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
01/01/1987Hepatitis BEngerixLiquid: ready to useVial20GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
29/03/2004Polio Vaccine - Oral (OPV) TrivalentPolio sabinLiquid: ready to useVial10GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
29/03/2004Polio Vaccine - Oral (OPV) TrivalentPolio sabinLiquid: ready to useVial20GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
09/03/2001Measles, Mumps and RubellaPriorixLyophilised active component to be reconstituted with excipient diluent before useVial1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
12/03/2009RotavirusRotarixLiquid: ready to usePlastic Tube1GlaxoSmithKline Biologicals SAFederal Agency for Medicines and Health Products
02/02/2006Polio Vaccine - Oral (OPV) TrivalentPolioviral vaccineLiquid: ready to useVial20Haffkine Bio Pharmaceutical Corporation LtdCentral Drugs Standard Control Organization
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial5Institut Pasteur de DakarMinistère de la Santé publique
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial20Institut Pasteur de DakarMinistère de la Santé publique
20/03/2001Yellow FeverStabilized Yellow Fever VaccineLyophilised active component to be reconstituted with excipient diluent before useVial10Institut Pasteur de DakarMinistère de la Santé publique
01/01/1987BCGBCG Freeze Dried Glutamate vaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule20Japan BCG LaboratoryChiba Local Government
22/11/1996Hepatitis BEuvax BLiquid: ready to useVial1LG Chem LtdMinistry of Food and Drug Safety
22/11/1996Hepatitis BEuvax BLiquid: ready to useVial10LG Chem LtdMinistry of Food and Drug Safety
01/02/1991BCGBCG VaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
01/02/1991BCGBCG VaccineLyophilised active component to be reconstituted with excipient diluent before useAmpoule20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Tetanus ToxoidTetatoxLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Tetanus ToxoidTetatoxLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-TetanusDiftetLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-TetanusDiftetLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-Tetanus (reduced antigen content)TetadifLiquid: ready to useVial10BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
09/05/2006Diphtheria-Tetanus (reduced antigen content)TetadifLiquid: ready to useVial20BB- NCIPD Ltd. (Bul Bio-National Center of Infectious and Parasitic Diseases Ltd.)Bulgarian Drug Agency
02/10/2013Diphtheria-Tetanus-Pertussis (whole cell)-Hepatitis B-Haemophilus influenzae type bEasyfive-TTLiquid: ready to useVial10Panacea Biotec Ltd.Central Drugs Standard Control Organization
22/07/1997Diphtheria-Tetanus (reduced antigen content)IMOVAX dT adultLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
09/12/2005Polio Vaccine - Inactivated (IPV)IMOVAX POLIOLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
16/06/2002Polio Vaccine - Oral (OPV) TrivalentOPVEROLiquid: ready to useVial20Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/07/1997Tetanus ToxoidTETAVAXLiquid: ready to useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/07/1997Tetanus ToxoidTETAVAXLiquid: ready to useVial20Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
01/04/1998Haemophilus influenzae type bAct-HIBLyophilised active component to be reconstituted with excipient diluent before useVial1Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
22/06/2005RabiesVERORABLyophilised active component to be reconstituted with excipient diluent before useVial1Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
01/01/1987Yellow FeverSTAMARILLyophilised active component to be reconstituted with excipient diluent before useVial10Sanofi Pasteur SAAgence nationale de sécurité du médicament et des produits de santé
12345



Count of vaccines is determined based on unique combination for:
[Vaccine Type] [Product Commercial Name] [Product Pharmaceutical Form] [Manufacturer] [Manufacturer Country]